Dalbavancin for Staph aureus Bacteremia, Telemedicine and Abortion Medication Access, Measles Insights, and more

Dalbavancin for Staph aureus Bacteremia, Tele...

Up next

Minor Papillotomy and Acute Pancreatitis, CNS-Active Medications in Older Adults, Trends in US Childhood Vaccination Exemptions, and more

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from January 10-16, 2026. 

Age-Adjusted D-Dimer Cutoffs, Pediatric Pain Management, Adolescent Smartphone Use, and more

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from January 3-9, 2026. 

Recommended Episodes

Geroscience in Medicine
JAMA Clinical Reviews

Geroscience aims to define and modify biologic pathways associated with aging and age-related diseases. Author Stephen B. Kritchevsky, PhD, of the Wake Forest University School of Medicine and JAMA Deputy Editor Mary M. McDermott, MD, discuss current evidence regarding geroscienc ...  Show more

Ophthalmology Reviews: A New Frontier in the Ophthalmology Family of Journals
Ophthalmology Journal

Ophthalmology Editor-in-Chief, Russell Van Gelder, MD, PhD, and our new Associate Editor, Laura Downie, BOptom, PhD, guest host this special episode introducing "Ophthalmology Reviews." <span style= "mso-spacerun: yes;"> </span>Ophthalmology Reviews ...

  Show more

Diagnosis and Management of Prostatitis
JAMA Clinical Reviews

Prostatitis affects approximately 9.3% of men in their lifetime and includes acute and chronic bacterial infection and nonbacterial chronic prostatitis with chronic pelvic pain syndrome. Author Minh N. Pham, MD, from University of North Carolina School of Medicine discusses this ...  Show more

Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
JACC This Week

Michelle M Kittleson, MD, FACC, JACC Associate Editor, speaks with author Muthiah Vaduganathan, MD on his accepted paper concerning the FINEARTS trial published in JACC.